MedTrace Logo

Safety of NGOIS Compared to BSS Plus in Pediatric Patients

NCT00346528 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2012-03-05

No results posted yet for this study

Summary

To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.

Conditions

  • Cataract

Interventions

DRUG

Next Generation Ophthalmic Irrigating Solution (NGOIS)

Volume sufficient to irrigate adequately during cataract surgery

DRUG

BSS Plus

Volume sufficient to irrigate adequately during cataract surgery

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Stephen Lane · Medical Monitor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Week
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00346528 on ClinicalTrials.gov